Latest Mass Spectrometry News

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

INOVIQ's December quarterly update reveals significant progress in its cancer diagnostic and therapeutic programs, including a highly accurate ovarian cancer screening test and promising breast cancer therapeutics, supported by growing EXO-NET customer adoption and a solid cash position.

Noble Helium has selected three initial drill sites in its North Rukwa Project in Tanzania, backed by significant helium detections and a flexible funding package including convertible notes and an equity facility. However, drilling has been deferred due to seasonal rains.